
Sign up to save your podcasts
Or


Plus: Shares in Novo Nordisk rally after the FDA clamps down on companies making compound versions of weight-loss drug Wegovy. And SpaceX delays a planned Mars mission to focus on Nasa’s next moon landing. Daniel Bach hosts.
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By The Wall Street Journal4.2
652652 ratings
Plus: Shares in Novo Nordisk rally after the FDA clamps down on companies making compound versions of weight-loss drug Wegovy. And SpaceX delays a planned Mars mission to focus on Nasa’s next moon landing. Daniel Bach hosts.
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices

2,842 Listeners

1,725 Listeners

4,413 Listeners

409 Listeners

436 Listeners

1,649 Listeners

1,448 Listeners

1,048 Listeners

1,309 Listeners

6,104 Listeners

1,580 Listeners

213 Listeners

1,322 Listeners

585 Listeners

152 Listeners

89 Listeners

81 Listeners

149 Listeners